The binding of complement component C3 to antibody-antigen aggregates after activation of the alternative pathway in human serum.

No abstract is available for this paper.

• Publication year

  1981

• Venue

  Biochemical Journal

• Publication date

  1981-05-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1042/BJ1950471PMID 7316962PMCID PMC1162911
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The covalent-binding reaction of complement component C3.

  1981cited by this paper
• Importance of the integrity of the inter-heavy-chain disulphide bond of rabbit IgG in the activation of the alternative pathway of human complement by the F(ab')2 region of rabbit IgG antibody in immune aggregates.

  1981cited by this paper
• The C1q receptor site on immunoglobulin G

  1980cited by this paper
• Third component of human complement: appearance of a sulfhydryl group following chemical or enzymatic inactivation.

  1980cited by this paper
• Solubilization of antigen-antibody complexes: a new function of complement as a regulator of immune reactions.

  1980cited by this paper
• The binding of human complement component C4 to antibody-antigen aggregates.

  1980cited by this paper
• Third component of human complement: structural requirements for its function.

  1980cited by this paper
• Methylamine reaction and denaturation-dependent fragmentation of complement component 3. Comparison with alpha2-macroglobulin.

  1980cited by this paper
• Evidence for presence of an internal thiolester bond in third component of human complement.

  1980cited by this paper
• The human complement system: assembly of the classical pathway C3 convertase.

  1980cited by this paper
• Limited proteolysis of complement components C2 and factor B. Structural analogy and limited sequence homology.

  1979cited by this paper
• Differential elution of Clq, Clr and Cls from human Cl bound to immune aggregates. Use in the rapid purification of Cl subcomponents.

  1979cited by this paper
• Action of the C3b-inactivator on the cell-bound C3b.

  1979cited by this paper
• Evidence for an ester linkage between the labile binding site of C3b and receptive surfaces.

  1979cited by this paper
• Activation of the first component of human complement (C1) by antibody-antigen aggregates.

  1978cited by this paper
• The assembly of early components of complement on antibody-antigen aggregates and on antibody-coated erythrocytes.

  1978cited by this paper
• A new function of the activated third component of complement: binding to C5, an essential step for C5 activation.

  1978cited by this paper
• The binding of activated C3 to polysaccharides and immunoglobulins.

  1978cited by this paper
• Interaction between the third complement protein and cell surface macromolecules.

  1977cited by this paper
• The activation mechanism of the alternative pathway of the human complement system by the immune precipitate formed with F(ab')2 of rabbit IgG antibody: the generation of C3- and C5-cleaving enzymes on the immune precipitate.

  1977cited by this paper
• Requirements for the solubilization of immune aggregates by complement: assembly of a factor B-dependent C3-convertase on the immune complexes

  1977cited by this paper
• The epsilon-(gamma-glutamyl)lysine crosslink and the catalytic role of transglutaminases.

  1977cited by this paper
• Third component of human complement: purification from plasma and physicochemical characterization.

  1976cited by this paper
• Complement.

  1975cited by this paper
• Activation of the alternate pathway of human complements by rabbit cells.

  1974cited by this paper
• Relationships of the catalytic properties of human plasma and platelet transglutaminases (activated blood coagulation factor XIII) to their subunit structures.

  1974cited by this paper
• Two complement interaction sites in guinea pig immunoglobulins.

  1971cited by this paper
• Complement fixation by the F(ab')2-fragment of pepsin-treated rabbit antibody.

  1971cited by this paper
• Variation in the N-terminal sequence of heavy chains of immunoglobulin G from rabbits of different allotype.

  1969cited by this paper
• A comparison of methods for the molecular quantitation of the fourth component of human complement.

  1968cited by this paper
• Structural studies of products of antigen-antibody-complement interaction.

  1968cited by this paper
• Physico-chemical characteristics of the third and fourth component of complement after dissociation from complement-cell complexes.

  1967cited by this paper
• Immune hemolysis: a simplified method for the preparation of EAC'4 with guinea pig or with human complement.

  1967cited by this paper
• Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum.

  1966cited by this paper
• THE REACTION MECHANISM OF β1C-GLOBULIN (C'3) IN IMMUNE HEMOLYSIS

  1966cited by this paper
• C'1 ESTERASE EFFECT ON ACTIVITY AND PHYSICOCHEMICAL PROPERTIES OF THE FOURTH COMPONENT OF COMPLEMENT

  1965cited by this paper
• Interaction of Autologous Complement with Red Cells in the Absence of Antibody. ∗ †

  1964cited by this paper
• ISOLATION AND DESCRIPTION OF THE FOURTH COMPONENT OF HUMAN COMPLEMENT

  1963cited by this paper
• The fractionation of rabbit gamma-globulin by partition chromatography.

  1955cited by this paper
• QUANTITATIVE CHEMICAL STUDIES ON COMPLEMENT OR ALEXIN

  1941cited by this paper

• Some Human Anti-Glycan Antibodies Lack the Ability to Activate the Complement System

  2024cites this paper
• Current Understanding of Complement Proteins as Therapeutic Targets for the Treatment of Immunoglobulin A Nephropathy

  2023cites this paper
• Antibody-Dependent Complement Responses toward SARS-CoV-2 Receptor-Binding Domain Immobilized on “Pseudovirus-like” Nanoparticles

  2022cites this paper
• Nephritis-Associated Plasmin Receptor (NAPlr): An Essential Inducer of C3-Dominant Glomerular Injury and a Potential Key Diagnostic Biomarker of Infection-Related Glomerulonephritis (IRGN)

  2022cites this paper
• Alternative pathway amplification and infections

  2022cites this paper
• The role of properdin in the pathogenesis of murine systemic lupus erythematosus

  2019cites this paper
• Acute-phase proteins during inflammatory reaction by bacterial infection: Fish-model

  2019cites this paper
• Effect of a C1s Inhibitor on the Efficacy of Anti-Capsular Antibodies against Neisseria meningitidis and Streptococcus pneumoniae

  2019cites this paper
• Immunoglobulin deposition on biomolecule corona determines complement opsonisation efficiency of preclinical and clinical nanoparticles

  2018cites this paper
• Complement proteins bind to nanoparticle protein corona and undergo dynamic exchange in vivo.

  2017cites this paper
• Serum albumin and osmolality inhibit Bdellovibrio bacteriovorus predation in human serum

  2017cites this paper
• A fully recombinant human IgG1 Fc multimer (GL-2045) inhibits complement-mediated cytotoxicity and induces iC3b.

  2017cites this paper
• Complement proteins bind to nanoparticle protein corona 1 and undergo dynamic exchange in vivo 2

  2016cites this paper
• Optimization of a flow cytometric assay to evaluate the human neutrophil ability to phagocytose immune complexes via Fcγ and complement receptors.

  2015cites this paper
• Kathryn Wood, DPhil, FMedSci: Professor of Immunology, University of Oxford and Editor of Transplantation, 1991-2014.

  2015cites this paper
• Human L-ficolin, a Recognition Molecule of the Lectin Activation Pathway of Complement, Activates Complement by Binding to Pneumolysin, the Major Toxin of Streptococcus pneumoniae

  2013cites this paper
• Naturally Occurring Anti-Band 3 Antibodies in Clearance of Senescent and Oxidatively Stressed Human Red Blood Cells

  2012cites this paper
• How Immune Complexes from Certain IgG NAbs and Any F(ab′)2 Can Mediate Excessive Complement Activation

  2012cites this paper
• Naturally occurring autoantibodies in mediating clearance of senescent red blood cells.

  2012cites this paper
• C 1 q-independent activation of neutrophils by immunoglobulin M-coated surfaces 1

  2012cites this paper
• vivo clearance High-dose intravenous immunoglobulin modifies complement-mediated in

  2011cites this paper
• Human F(ab')2-containing immune complexes together with anti-hinge natural antibodies stimulate complement amplification in vitro and in vivo.

  2008cites this paper
• Stimulation of complement amplification by F(ab')(2)-containing immune complexes and naturally occurring anti-hinge antibodies, possible role in systemic inflammation.

  2008cites this paper
• Superoxide anion production by neutrophils is associated with prevalent clinical manifestations in systemic lupus erythematosus

  2008cites this paper
• Neutrophil effector functions triggered by Fc-gamma and/or complement receptors are dependent on B-ring hydroxylation pattern and physicochemical properties of flavonols.

  2007cites this paper
• Opinion paper: Stimulation of complement amplification or activation of the alternative pathway of complement?

  2007cites this paper
• SUBSTANCES THAT CAN TRIGGER ACTIVATION OF THE ACTIVITY IN MICE

  2006cites this paper
• Introduction of the President of the Transplantation Society, Kathryn Wood

  2006cites this paper
• Complement amplification revisited.

  2006cites this paper
• Neutrophils from Brazilian patients with Graves' disease: some biochemical and functional aspects

  2005influential citation
• Anti-inflammatory effect of intravenous immunoglobulin mediated through modulation of complement activation

  2005cites this paper
• The role of antibody in the activation of the alternative complement pathway

  2005cites this paper
• Intravenously applied IgG stimulates complement attenuation in a complement-dependent autoimmune disease at the amplifying C3 convertase level.

  2004cites this paper
• The Complement—Fixing Activity of Immune Complexes Containing IgG Antibodies of Different Functional Affinities: Effects on Superoxide Production by Rabbit Neutrophils

  2004influential citation
• Activation and Inhibition of Complement by Immunoglobulins

  2004cites this paper
• C3b2-IgG Complexes Retain Dimeric C3 Fragments at All Levels of Inactivation*

  2003cites this paper
• Preparation and Isolation of Soluble Antigen ( Ag )-Antibody ( Ab )-Complement ( C ) Complexes ( Ag : Ab : C ) .

  2003cites this paper
• An anti-C3b(i) mAb enhances complement activation, C3b(i) deposition, and killing of CD20+ cells by rituximab.

  2003cites this paper
• The role of complement in the modulation by fluid-phase IgG of the production of reactive oxygen species by polymorphonuclear leukocytes stimulated with IgG immune complexes.

  2003cites this paper
• On the binding of complement to solid artificial surfaces in vitro.

  2002cites this paper
• Serine 132 is the C3 covalent attachment point on the CH1 domain of human IgG1.

  2001cites this paper
• C1q-independent activation of neutrophils by immunoglobulin M-coated surfaces.

  2001cites this paper
• A C3 convertase assay for nephritic factor functional activity.

  2001cites this paper
• Interaction of C3b(2)--IgG complexes with complement proteins properdin, factor B and factor H: implications for amplification.

  2000cites this paper
• Immunoglobulin in the control of complement action

  2000cites this paper
• Targeting of cancer cells with monoclonal antibodies specific for C3b(i)

  2000cites this paper
• How pre-existing, germline-derived antibodies and complement may help induce a primary immune response to nonself.

  1999cites this paper
• Assembly and regulation of the complement amplification loop in blood: the role of C3b-C3b-IgG complexes.

  1999cites this paper
• The covalent interaction of C3 with IgG immune complexes.

  1999cites this paper
• How Pre‐existing, Germline‐Derived Antibodies and Complement May Help Induce a Primary Immune Response to Nonself

  1999cites this paper
• CHAPTER 6 – Interactions Outside the Antigen-Combining Site

  1998cites this paper
• Components and Reactivity

  1998cites this paper
• Predominant role of the Fab fragment in delaying hyperacute rejection in guinea pig-to-rat xenotransplantation.

  1998cites this paper
• The C(H)1 domain of IgG is not essential for C3 covalent binding: importance of the other constant domains as targets for C3.

  1998cites this paper
• Immune complex glomerulonephritis in C4- and C3-deficient mice.

  1998cites this paper
• Complement-dependent Proinflammatory Properties of the Alzheimer's Disease β-Peptide

  1998cites this paper
• Targeted Disruption of the Murine Gene Coding for the Third Complement Component (C3)

  1998cites this paper
• The internal thioester and the covalent binding properties of the complement proteins C3 and C4

  1997cites this paper
• Use of Intravenous Immunoglobulin as a Therapeutic Approach To Prevent Rejection Between Widely Disparate Species

  1997cites this paper
• Beneficial effects of systemic immunoglobulin in experimental membranous nephropathy.

  1996cites this paper
• [The interaction between the complement system and immune complexes].

  1996cites this paper
• Tubing loops as a model for cardiopulmonary bypass circuits: Both the biomaterial and the blood-gas phase interfaces induce complement activation in anin vitro model

  1996cites this paper
• High doses of immunoglobulin G attenuate immune aggregate-mediated complement activation by enhancing physiologic cleavage of C3b in C3bn-IgG complexes.

  1996cites this paper
• Effect of immunoglobulin variable region structure on C3b and C4b deposition.

  1996cites this paper
• Intravenous immunoglobulins in the therapy of autoimmune and systemic inflammatory disorders.

  1995cites this paper
• An indirect effect of an antibody on complement deposition and lysis of differently sensitized surrounding cells.

  1994cites this paper
• The alternative complement pathway promotes IgM antibody‐dependent and ‐independent adherence of Bacteroides to polymorphonuclear leukocytes through CR3 and CR1

  1994cites this paper
• Covalent attachment of human complement C3 to IgG. Identification of the amino acid residue involved in ester linkage formation.

  1994cites this paper
• Crystallization of human methylamine-treated complement C3 and C3b.

  1994cites this paper
• Complement activation on solid surfaces as determined by C3 deposition and hemolytic consumption.

  1994cites this paper
• The role of the carbohydrate chains in complement (C3) fixation by solid-phase-bound human IgA.

  1994cites this paper
• C3 binds with similar efficiency to Fab and Fc regions of IgG immune aggregates

  1994cites this paper
• Effector functions of a mouse IgG that lacks the entire CH1 domain. C1q binding and complement fixation in the absence of antigen.

  1993cites this paper
• Activated C3 (C3b) in the nephritic glomerulus

  1993cites this paper
• Preferential formation of C3b-IgG complexes in vitro and in vivo from nascent C3b and naturally occurring anti-band 3 antibodies.

  1993cites this paper
• Identification of a major binding site for complement C3 on the IgG1 heavy chain.

  1993cites this paper
• Differences in the activity of the alternative pathway of complement in BALB/c and C57Bl/6 mice.

  1993cites this paper
• Disulfide bridges in human complement component C3b

  1993cites this paper
• Antibacterial and protective properties of monoclonal antibodies reactive with Escherichia coli O111:B4 lipopolysaccharide: relation to antibody isotype and complement-fixing activity.

  1992cites this paper
• Systemic lupus erythematosus: Complexes and their clearance

  1992cites this paper
• Dissociation of primary antigen-antibody bonds is essential for complement mediated solubilization of immune precipitates.

  1992cites this paper
• In vivo binding and clearance of circulating antigen by bispecific heteropolymer-mediated binding to primate erythrocyte complement receptor.

  1992cites this paper
• Generation of iC3 at the Interface between Blood and Gas

  1992cites this paper
• Complexes of IgG molecules and C3a and C4a complement components in human serum

  1992cites this paper
• Conformational differences between surface-bound and fluid-phase complement-component-C3 fragments. Epitope mapping by cDNA expression.

  1992cites this paper
• Human antibody effector function.

  1992cites this paper
• Naturally occurring anti-band 3 antibodies.

  1992cites this paper
• Formation of covalently linked C3‐C3 dimers on IgG immune aggregates

  1991cites this paper
• Opsonic potential of C3b-anti-band 3 complexes when generated on senescent and oxidatively stressed red cells or in fluid phase.

  1991cites this paper
• Complement-opsonized IgG antibody/dsDNA immune complexes bind to CR1 clusters on isolated human erythrocytes.

  1991cites this paper
• Localization of the human complement component C3 binding site on the IgG heavy chain.

  1991cites this paper
• Specificity of bovine serum antibody to capsular carbohydrate antigens from Pasteurella haemolytica

  1990cites this paper
• Neoantigens in complement component C3 as detected by monoclonal antibodies. Mapping of the recognized epitopes by synthetic peptides.

  1990cites this paper
• Inhibition of factor I by diisopropylfluorophosphate. Evidence of conformational changes in factor I induced by C3b and additional studies on the specificity of factor I.

  1990cites this paper
• C3, C4, and the terminal complement complex differ from C1q by binding predominantly to the antigenic part of solid phase immune complexes.

  1990cites this paper
• The role of naturally-occurring antibodies against man-made materials in biocompatibility

  1990cites this paper
• Targeting of complement to tumor cells by heteroconjugates composed of antibodies and of the complement component C3b.

  1989cites this paper
• Anti‐inflammatory activity of human IgA antibodies and their Fabα fragments: inhibition of IgG‐mediated complement activation

  1989cites this paper
• Complete intron/exon organization of DNA encoding the alpha' chain of human C3.

  1989cites this paper
• Complement activation in human lymphoid germinal centres.

  1989cites this paper